BSE Live
Dec 29, 09:35Prev. Close
1719.20
Open Price
1719.50
Bid Price (Qty.)
1720.85 (40)
Offer Price (Qty.)
1721.65 (16)
NSE Live
Dec 29, 09:36Prev. Close
1719.50
Open Price
1719.50
Bid Price (Qty.)
1720.90 (2)
Offer Price (Qty.)
1721.20 (217)
| Cash Flow of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 323.48 | 294.01 | |
| Net CashFlow From Operating Activities | 219.81 | 329.95 | |
| Net Cash Used In Investing Activities | -863.44 | -531.70 | |
| Net Cash Used From Financing Activities | 1,457.89 | 198.81 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 814.26 | -2.95 | |
| Cash And Cash Equivalents Begin of Year | 75.77 | 78.70 | |
| Cash And Cash Equivalents End Of Year | 890.03 | 75.75 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend